Skip to main content

Home/ NPR-like radio blurb/ Group items tagged General Info

Rss Feed Group items tagged

Krysten Powell

memantine.com - Innovation for Alzheimer Patients - 0 views

shared by Krysten Powell on 28 Oct 09 - Cached
  •  
    Memantine Website General Info about Drug and video on Mechanism of Action
  •  
    This is the website for the NMDA receptor antagonist Memantine. It provides some general information about this class of AD treatment drugs. Since our project mentions the broad categories of AD drugs (NMDA receptor antagonists and cholinesterase inhibitors) this was useful to research the mechanism of action.
Rowley Rice

Alzheimer's Disease Drug Development in 2008 and Beyond: Problems and Opportunities - 1 views

  • To identify and counter risks we considered the relevance to AD drug development of the following factors: (1) effective dosing of the drug product, (2) reliable evaluations of research subjects, (3) effective implementation of quality controls over data at research sites, (4) resources for practitioners to effectively use CT results in patient care, (5) effective disease modeling, (6) effective research designs.
  • encountered in AD drug development can be avoided by changing practices. Current problems with human errors in clinical trials make it difficult to differentiate drugs that fail to evidence efficacy from apparent failures due to Type II errors.
  •  
    Another article about the common reasons that Alzheimer's studies are flawed.
  •  
    This articles identifies and discusses drug development in Alzheimer's disease in 2008, the difficulties with these drugs and the possible opportunities. By addressing issues evident in clinical trials, this source expounds upon the common reason why Alzheimer's studies are flawed. This article is a helpful source because it has informed us on the drug development process, the effectiveness and ineffectiveness of drugs on the market.
1 - 2 of 2
Showing 20 items per page